Search results
FDA grants IND authorisation for Synaptogenix’s multiple sclerosis trial
Clinical Trials Arena· 5 days agoThe fully-funded, open-label trial will be conducted and handled at the Cleveland Clinic...
AbbVie gains FDA approval for EPKINLY in follicular lymphoma
Pharmaceutical Technology· 5 days agoAbbVie will manage global commercialisation of the asset. The FDA’s decision is based on the Phase I...
ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
Clinical Trials Arena· 7 days agoIt has the same antibody as the Gilead...
Translational research: Out of the lab, into the clinic
Pharmaceutical Technology· 16 hours agoTurning a research project into results that can directly benefit people is complex, time consuming,...
AstraZeneca makes another obesity play funnelling $80m into SixPeaks Bio
Clinical Trials Arena· 7 days agoOther pharma giants are also making waves in this space. Last week, Roche reported positive results...
Resolution Therapeutics gets green light from UK for macrophage cell therapy study
Clinical Trials Arena· 5 days agoRTX001 is an engineered...preclinical data demonstrating anti-fibrotic and anti-inflammatory...
BMS expands Krazati’s FDA label to include colorectal cancer
Clinical Trials Arena· 7 days agoIn October 2023, the company presented positive data from the Phase III CodeBreak 300 trial...
Capturing the genAI boom for drug development
Pharmaceutical Technology· 5 days agoWhile companies are not mandated to follow these recommendations, they will become increasingly important. Data suggests the AI-discovered molecules are...
ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
Pharmaceutical Technology· 7 days agoIt has the same antibody as the Gilead...
FDA Approves Skyrizi for Ulcerative Colitis
Verywell Health· 4 days agoThe FDA approves Skyrizi for the treatment of Ulcerative colitis. Here's what approval means and how the drug compares to other treatment options...
